Home
Foresite Capital Fund IV reported a 9.2% stake in Lyell Immunopharma LYEL · 27,161,892 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 9.2%
- Last report
- 6.7% · filed 25/02/14
- Shares held
- 27,161,892 sh
- Class
- Common Stock, par value $0.0001
- Holder
- Foresite Capital Fund IV
- Event date
- 25/03/31
- Filed
- 25/05/15
9.2% stake · +2.5pp from the last report
- Stake
- 9.2%
- Last report
- 6.7%
- Since last report
- +2.5pp
Lyell Immunopharma trades, last 26 weeks
What else happened in Lyell Immunopharma around then
Filed or reported within 30 days of the trade day · 25/03/01~25/04/30Foresite Capital Fund IV's other 5% stake reports
- Foresite Capital Fund IV
5% stakeLyell Immunopharma
5% stakeLyell Immunopharma
LYEL
2.7% stake
653,328 sh
2.7% stake
Filed 08/14
- Foresite Capital Fund IV
5% stakeEikon Therapeutics
5% stakeEikon Therapeutics
EIKN
7.7% stake
4,148,519 sh
7.7% stake
Filed 02/11
- Foresite Capital Fund IV
5% stakeLyell Immunopharma
5% stakeLyell Immunopharma
LYEL
7.6% stake
1,454,616 sh
7.6% stake
Filed 25/11/14
- Foresite Capital Fund IV
5% stakeMaze Therapeutics
5% stakeMaze Therapeutics
MAZE
1.4% stake
608,948 sh
1.4% stake
Filed 25/11/14
- Foresite Capital Fund IV
5% stakeMaze Therapeutics
5% stakeMaze Therapeutics
MAZE
5.6% stake
2,457,108 sh
5.6% stake
Filed 25/02/07
